No abstract available.
Encephalitis, Arbovirus* ; Prognosis*

No abstract available.
Meconium*

No abstract available.
Knee Joint* ; Knee*

No abstract available.
Bronchopulmonary Sequestration*

No abstract available.
Esophageal Atresia* ; Tracheoesophageal Fistula*

No abstract available.
Glomerulonephritis*

BACKGROUND AND OBJECTIVES:The chemical labyrinthectomy with aminoglycoside is a good method for vertigo control in Meniere's disease. It is relatively non-invasive and easy procedure, but hearing loss is a awful complication. We aimed to evaluate the relationship between the change in the degree of canal paresis in bithermal caloric test and the degree of hearing change. MATERIALS AND METHODS:Sixty-five patients of Meniere's disease who underwent chemical labyrinthectomy with streptomycin between October 1997 and December 2001 were included in this study. The minimum follow-up period for the patients was 24 months. Medical records were analyzed retrospectively. Criteria had been prescribed in 1995 by the American Academy of Otolaryngology-Head and Neck Surgery were used. Forty patients were tested a caloric response before and after the chemical labyrinthectomy. We analyzed the vertigo control rate, the change of the canal paresis and the change of hearing level. RESULTS:Vertigo was controlled in 90.8% of the 65 patients. Twelve patients of total 65 patients were decreased hearing level more than 10 dB after this procedure. Even though the severity of canal paresis increased, the hearing ability of most patients was unaffected. Some patients who had only slight canal paresis happened to suffer from hearing loss. CONCLUSION:There was no correlation between the change in the degree of canal paresis in the bithermal caloric test and the degree of the hearing change.
Caloric Tests* ; Ear, Inner ; Follow-Up Studies ; Hearing Loss* ; Hearing* ; Humans ; Medical Records ; Meniere Disease* ; Neck ; Paresis* ; Retrospective Studies ; Streptomycin ; Vertigo

BACKGROUND: Bentonite clay, which is a major component of mud pack, has been used for various purposes in cosmetics. Glycolic acid is known to be effective in the treatment of acne. Al-though those products are used widely, information on the mode of action and effects on the skin are little and controversial till now. OBJECTIVE: To investigate whether bentonite alone, or bentonite with glycolic acid in mixed formulation affect the stratum corneum leading to alteration on cutaneous barrier function and whether those products alter the lipid lamellae and desmosomes of corneocytes. MATERIALS AND METHODS: Mud pack-type ointment of bentonite, bentonite and 5% glycolic acid formulation, bentonite and 10% glycolic acid formulation were applied on the volar fore-arm of the five healthy men and flank skin of five 6-8 week old hairless mice. Transepidermal water loss and capacitance were measured. Electron microscopic examination after ruthenium tetroxide postfixation was performed on the flank skin of the mice. RESULTS: Transepidermal water loss(TEWL) increased immediately and normalized 4 to 6 hours later after removal of vapor permeable membrane in both mouse and human. Capacitance did not show any evidence of change in the water content of the stratum corneum. Electron microscopic examination revealed that lipid lamellae and desmosome of corneocytes were not de-graded, but lamellar body secretion and partially electron-lucent material was-increased in 10% glycolic acid and bentonite mixture-treated area. CONCLUSION: Barrier function of stratum corneum is not disturbed by bentonite and glycolic acid formulations at the concentration used. Barrier structures are not disrupted, but lamellar body secretion and partially electron-lucent material was increased by bentonite and glycolic acid formulations at higher concentration.
Acne Vulgaris ; Animals ; Bentonite* ; Desmosomes ; Humans ; Male ; Membranes ; Mice ; Mice, Hairless ; Mud Therapy ; Ruthenium ; Skin ; Water

No abstract available.
Cleidocranial Dysplasia*

With the aim of reversing myopic regression after PRK, the effect of highdose topical corticosteroid in modulating changes in refraction and corneal transparency were assessed prospectively. Seventy-two eyes of 62 patients (mean preoperative SE -6.14D; -2.30 D to -11.50D), demonstrating myopic regression ranging between -0.75D to -5.33D (mean: -1.69D), were treated with 0.1% dexamethasone eye solution five times a day for averaging 2.8 weeks. The age of patient, amount of attempted correction and K-reading did not influenced statistically significantly on myopic regression. Uncorrected visual acuity, mean refraction before reintroducing corticosteroids (mean: 0.58, -1.69D) improved after corticosteroid treatment (mean: 0.85, -0.42D)(p<0.01). Corneal haze changed statistically significant from 0.80 +/- 0.61 to 0.53 +/- 0.40 after steroid treatment(p<0.01). Topical corticosteroid therapy can modulate refractive changes after PRK, appearing to improve myopic regression. However, a long term follow up will be necessary to determine the final refractive outcome of these eyes.
Adrenal Cortex Hormones ; Dexamethasone ; Follow-Up Studies ; Humans ; Lasers, Excimer ; Photorefractive Keratectomy* ; Prospective Studies ; Visual Acuity